These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28460622)

  • 1. Intravesical Chemotherapy and Chemohyperthermia in Non-Muscle-Invasive Bladder Cancer; An Overview on Drug Administration Technologies and Pharmacokinetics.
    Campodonico F; Di Stasi S; Lev GM; Terrone C; Bongiovanni L; Mattioli F; Pagliarulo V; Introini C
    Curr Drug Metab; 2017; 18(7):657-665. PubMed ID: 28460622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical device-assisted therapies for non-muscle-invasive bladder cancer.
    Tan WS; Kelly JD
    Nat Rev Urol; 2018 Nov; 15(11):667-685. PubMed ID: 30254383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer.
    van Valenberg H; Colombo R; Witjes F
    Int J Hyperthermia; 2016 Jun; 32(4):351-62. PubMed ID: 26905963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations.
    Liem EI; Crezee H; de la Rosette JJ; de Reijke TM
    Int J Hyperthermia; 2016 Jun; 32(4):363-73. PubMed ID: 27056069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
    Irani J
    Prog Urol; 2016 Nov; 26(14):860-864. PubMed ID: 27712914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion.
    Colombo R; Brausi M; Da Pozzo L; Salonia A; Montorsi F; Scattoni V; Roscigno M; Rigatti P
    Eur Urol; 2001 Jan; 39(1):95-100. PubMed ID: 11173946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of device-assisted therapies in the management of non-muscle invasive bladder cancer: A systematic review.
    Carando R; Pradere B; Afferi L; Marra G; Aziz A; Roghmann F; Krajewski W; Di Bona C; Alvarez-Maestro M; Pagliarulo V; Xylinas E; Moschini M
    Prog Urol; 2020 May; 30(6):322-331. PubMed ID: 32279953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer.
    Slater SE; Patel P; Viney R; Foster M; Porfiri E; James ND; Montgomery B; Bryan RT
    Ann R Coll Surg Engl; 2014 Sep; 96(6):415-9. PubMed ID: 25198970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical drug delivery into the bladder to treat cancers.
    Fang JY; Huang ZR
    Curr Drug Deliv; 2009 Jul; 6(3):227-37. PubMed ID: 19604136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-muscle invasive bladder cancer: safety of postoperative EMDA-assisted instillation of mitomycin].
    Rehme C; Niedworok C; Rübben H; Vom Dorp F
    Urologe A; 2015 Feb; 54(2):235-8. PubMed ID: 25316185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.].
    Coenen JJMJH; van Valenberg FJP; Arends TJH; Witjes JA
    Arch Esp Urol; 2018 May; 71(4):400-408. PubMed ID: 29745929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C for the treatment of bladder cancer.
    Volpe A; Racioppi M; D'Agostino D; Cappa E; Filianoti A; Bassi PF
    Minerva Urol Nefrol; 2010 Jun; 62(2):133-44. PubMed ID: 20562793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer.
    Arends TJ; van der Heijden AG; Witjes JA
    J Urol; 2014 Sep; 192(3):708-13. PubMed ID: 24704017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancer.
    Hendricksen K; Witjes JA
    Curr Opin Urol; 2007 Sep; 17(5):352-7. PubMed ID: 17762630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration.
    Pierconti F; Rossi ED; Straccia P; Fadda G; Larocca LM; Bassi PF; Sacco E; Schinzari G
    Cancer Cytopathol; 2018 Mar; 126(3):200-206. PubMed ID: 29360198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
    Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H
    Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
    [No Abstract]   [Full Text] [Related]  

  • 19. Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer.
    Sousa A; Piñeiro I; Rodríguez S; Aparici V; Monserrat V; Neira P; Carro E; Murias C; Uribarri C
    Int J Hyperthermia; 2016 Jun; 32(4):374-80. PubMed ID: 26915466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective comparison of intra-arterial chemotherapy combined with intravesical chemotherapy and intravesical chemotherapy alone after transurethral resection with a thulium laser in high-risk non-muscle invasive bladder cancer.
    Sun F; Zhao R; Zhu Y; Cui D; Wang X; Han B; Liang S; Liu H; Sun X; Zhao F; Xu D; Xia S
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1099-1107. PubMed ID: 28421294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.